The system – which already has a breakthrough device designation from the FDA – will take the form of a small patch-like device similar to Abbott's FreeStyle Libre 3 device (pictured above ...

Thereafter, you need to prick your finger to retrieve a sample of blood and then place the sample on the edge of the test ...

Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus* sensor, is now available to Canadians living with diabetes.

Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before.

Of late, the company has been fast gaining momentum, leveraging consistent upgrades of FreeStyle Libre. In 2024, Abbott obtained FDA approvals for two new over-the-counter continuous glucose ...

Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion July 02, 2025 — 10:01 am EDT Written by Zacks Equity Research for Zacks -> ...

Per the Zacks Consensus Estimate, the company’s revenues for 2025 are expected to increase 10.6%. More on t:slim X2’s Compatibility With FreeStyle Libre 3 Plus ...

SAN DIEGO, June 20, 2025--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with Control-IQ+ ...

This Villa Libre guide explains everything you need to know about the facility, including location details, connection level rewards, and a list of all Sub Orders, Standard Orders, and Aid Requests.

Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States Business Wire Jun 20, 2025 ...

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...